ORMP - Oramed Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $8.78. This is a potential upside of $6.37 (264.32%) from yesterday's end of day stock price of $2.41.

Oramed Pharmaceuticals's activity chart (see below) currently has 31 price targets and 31 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 76.43% with an average time for these price targets to be met of 595.43 days.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 08-Sep-2024. First documented stock forecast 03-Dec-2013.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

1 years 1 months 5 days ago
(08-Sep-2024)

3/5 (60%)

$18.28 (133.24%)

278

Hold

$2

$-0.41 (-17.01%)

$3

2 years 4 months 27 days ago
(16-May-2023)

3/4 (75%)

$-1.63 (-44.90%)

157

Buy

$35

3 years 4 months 28 days ago
(15-May-2022)

1/2 (50%)

$9.92 (39.55%)

62

Buy

$40

$37.78 (1701.80%)

$11

3 years 11 months 5 days ago
(09-Nov-2021)

1/2 (50%)

$10.78 (36.89%)

6

Buy

$6

$3.59 (148.96%)

$7

5 years 7 months 17 days ago
(26-Feb-2020)

3/3 (100%)

$2.05 (51.90%)

915

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ORMP (Oramed Pharmaceuticals) average time for price targets to be met?

On average it took 595.43 days on average for the stock forecasts to be realized with a an average price target met ratio 76.43

Which analyst has the current highest performing score on ORMP (Oramed Pharmaceuticals) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the current lower performing score on ORMP (Oramed Pharmaceuticals) with a proven track record?

ANDREW D'SILVA

Which analyst has the most public recommendations on ORMP (Oramed Pharmaceuticals)?

Raghuram Selvaraju has 3 price targets and 18 ratings on ORMP

Which analyst is the currently most bullish on ORMP (Oramed Pharmaceuticals)?

Jim Molloy with highest potential upside - $37.78

Which analyst is the currently most reserved on ORMP (Oramed Pharmaceuticals)?

Edward Nash with lowest potential downside - -$0.41

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?